vs

Side-by-side financial comparison of Community Healthcare Trust Inc (CHCT) and RxSight, Inc. (RXST). Click either name above to swap in a different company.

RxSight, Inc. is the larger business by last-quarter revenue ($32.6M vs $30.9M, roughly 1.1× Community Healthcare Trust Inc). Community Healthcare Trust Inc runs the higher net margin — 46.6% vs -28.1%, a 74.7% gap on every dollar of revenue. On growth, Community Healthcare Trust Inc posted the faster year-over-year revenue change (5.6% vs -18.9%). Community Healthcare Trust Inc produced more free cash flow last quarter ($35.9M vs $-2.3M). Over the past eight quarters, RxSight, Inc.'s revenue compounded faster (5.1% CAGR vs 2.7%).

Medical Properties Trust, Inc. (MPT) is an international real estate investment trust (REIT) based in Birmingham, Alabama that purchases and invests in healthcare facilities and for-profit healthcare holding companies, primarily in the United States and Europe. Their property acquisitions often come in the form of sale-leaseback agreements, in which the original property owner sells the property to MPT and becomes their tenant. MPT's tenants are generally subject to long-term triple net lease...

RxSight, Inc. is a medical technology company focused on developing and commercializing innovative intraocular lens solutions for patients undergoing cataract and refractive lens exchange procedures. Its flagship Light Adjustable Lens allows post-surgery power adjustment via a dedicated light delivery device, serving global ophthalmology care markets to improve post-operative visual outcomes for patients.

CHCT vs RXST — Head-to-Head

Bigger by revenue
RXST
RXST
1.1× larger
RXST
$32.6M
$30.9M
CHCT
Growing faster (revenue YoY)
CHCT
CHCT
+24.5% gap
CHCT
5.6%
-18.9%
RXST
Higher net margin
CHCT
CHCT
74.7% more per $
CHCT
46.6%
-28.1%
RXST
More free cash flow
CHCT
CHCT
$38.2M more FCF
CHCT
$35.9M
$-2.3M
RXST
Faster 2-yr revenue CAGR
RXST
RXST
Annualised
RXST
5.1%
2.7%
CHCT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CHCT
CHCT
RXST
RXST
Revenue
$30.9M
$32.6M
Net Profit
$14.4M
$-9.2M
Gross Margin
77.5%
Operating Margin
-34.8%
Net Margin
46.6%
-28.1%
Revenue YoY
5.6%
-18.9%
Net Profit YoY
687.6%
-54.1%
EPS (diluted)
$0.52
$-0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CHCT
CHCT
RXST
RXST
Q4 25
$30.9M
$32.6M
Q3 25
$31.1M
$30.3M
Q2 25
$29.1M
$33.6M
Q1 25
$30.1M
$37.9M
Q4 24
$29.3M
$40.2M
Q3 24
$29.6M
$35.3M
Q2 24
$27.5M
$34.9M
Q1 24
$29.3M
$29.5M
Net Profit
CHCT
CHCT
RXST
RXST
Q4 25
$14.4M
$-9.2M
Q3 25
$1.6M
$-9.8M
Q2 25
$-12.6M
$-11.8M
Q1 25
$1.6M
$-8.2M
Q4 24
$1.8M
$-5.9M
Q3 24
$1.7M
$-6.3M
Q2 24
$-10.4M
$-6.1M
Q1 24
$3.7M
$-9.1M
Gross Margin
CHCT
CHCT
RXST
RXST
Q4 25
77.5%
Q3 25
79.9%
Q2 25
74.9%
Q1 25
74.8%
Q4 24
71.6%
Q3 24
71.4%
Q2 24
69.5%
Q1 24
70.1%
Operating Margin
CHCT
CHCT
RXST
RXST
Q4 25
-34.8%
Q3 25
-40.1%
Q2 25
-41.6%
Q1 25
-28.2%
Q4 24
-21.5%
Q3 24
-26.1%
Q2 24
-23.9%
Q1 24
-36.2%
Net Margin
CHCT
CHCT
RXST
RXST
Q4 25
46.6%
-28.1%
Q3 25
5.3%
-32.4%
Q2 25
-43.2%
-35.0%
Q1 25
5.3%
-21.6%
Q4 24
6.3%
-14.8%
Q3 24
5.9%
-17.9%
Q2 24
-37.9%
-17.4%
Q1 24
12.5%
-30.8%
EPS (diluted)
CHCT
CHCT
RXST
RXST
Q4 25
$0.52
$-0.22
Q3 25
$0.03
$-0.24
Q2 25
$-0.50
$-0.29
Q1 25
$0.03
$-0.20
Q4 24
$0.04
$-0.14
Q3 24
$0.04
$-0.16
Q2 24
$-0.42
$-0.16
Q1 24
$0.11
$-0.25

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CHCT
CHCT
RXST
RXST
Cash + ST InvestmentsLiquidity on hand
$3.3M
$228.1M
Total DebtLower is stronger
$532.2M
Stockholders' EquityBook value
$429.4M
$275.7M
Total Assets
$990.8M
$311.8M
Debt / EquityLower = less leverage
1.24×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CHCT
CHCT
RXST
RXST
Q4 25
$3.3M
$228.1M
Q3 25
$3.4M
$227.5M
Q2 25
$4.9M
$227.5M
Q1 25
$2.3M
$229.3M
Q4 24
$4.4M
$237.2M
Q3 24
$2.8M
$237.1M
Q2 24
$734.0K
$233.3M
Q1 24
$3.8M
$125.4M
Total Debt
CHCT
CHCT
RXST
RXST
Q4 25
$532.2M
Q3 25
$530.1M
Q2 25
$500.1M
Q1 25
$496.0M
Q4 24
$486.0M
Q3 24
$473.7M
Q2 24
$457.6M
Q1 24
$442.3M
Stockholders' Equity
CHCT
CHCT
RXST
RXST
Q4 25
$429.4M
$275.7M
Q3 25
$426.8M
$276.0M
Q2 25
$437.8M
$278.0M
Q1 25
$461.3M
$279.3M
Q4 24
$476.0M
$281.2M
Q3 24
$477.2M
$277.3M
Q2 24
$497.8M
$275.2M
Q1 24
$511.6M
$163.9M
Total Assets
CHCT
CHCT
RXST
RXST
Q4 25
$990.8M
$311.8M
Q3 25
$987.3M
$308.5M
Q2 25
$966.3M
$309.0M
Q1 25
$985.1M
$313.0M
Q4 24
$992.6M
$318.6M
Q3 24
$981.8M
$310.5M
Q2 24
$983.2M
$305.5M
Q1 24
$982.7M
$183.2M
Debt / Equity
CHCT
CHCT
RXST
RXST
Q4 25
1.24×
Q3 25
1.24×
Q2 25
1.14×
Q1 25
1.08×
Q4 24
1.02×
Q3 24
0.99×
Q2 24
0.92×
Q1 24
0.86×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CHCT
CHCT
RXST
RXST
Operating Cash FlowLast quarter
$56.4M
$-1.1M
Free Cash FlowOCF − Capex
$35.9M
$-2.3M
FCF MarginFCF / Revenue
116.0%
-6.9%
Capex IntensityCapex / Revenue
66.3%
3.5%
Cash ConversionOCF / Net Profit
3.91×
TTM Free Cash FlowTrailing 4 quarters
$62.8M
$-19.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CHCT
CHCT
RXST
RXST
Q4 25
$56.4M
$-1.1M
Q3 25
$12.7M
$-1.2M
Q2 25
$13.8M
$-4.4M
Q1 25
$14.4M
$-8.8M
Q4 24
$58.9M
$-4.3M
Q3 24
$13.8M
$650.0K
Q2 24
$16.7M
$-4.0M
Q1 24
$12.6M
$-9.3M
Free Cash Flow
CHCT
CHCT
RXST
RXST
Q4 25
$35.9M
$-2.3M
Q3 25
$7.6M
$-1.8M
Q2 25
$9.6M
$-5.9M
Q1 25
$9.7M
$-9.4M
Q4 24
$34.2M
$-5.1M
Q3 24
$6.7M
$-453.0K
Q2 24
$9.5M
$-5.5M
Q1 24
$7.5M
$-11.3M
FCF Margin
CHCT
CHCT
RXST
RXST
Q4 25
116.0%
-6.9%
Q3 25
24.6%
-5.8%
Q2 25
32.9%
-17.6%
Q1 25
32.3%
-24.8%
Q4 24
116.9%
-12.7%
Q3 24
22.5%
-1.3%
Q2 24
34.7%
-15.9%
Q1 24
25.7%
-38.2%
Capex Intensity
CHCT
CHCT
RXST
RXST
Q4 25
66.3%
3.5%
Q3 25
16.3%
1.9%
Q2 25
14.5%
4.6%
Q1 25
15.6%
1.5%
Q4 24
84.1%
2.1%
Q3 24
24.2%
3.1%
Q2 24
26.1%
4.4%
Q1 24
17.4%
6.7%
Cash Conversion
CHCT
CHCT
RXST
RXST
Q4 25
3.91×
Q3 25
7.76×
Q2 25
Q1 25
9.06×
Q4 24
32.14×
Q3 24
7.92×
Q2 24
Q1 24
3.45×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CHCT
CHCT

Segment breakdown not available.

RXST
RXST

Rxlal$28.2M86%
LDD$3.0M9%
Service Warranty Service Contracts And Accessories$1.5M4%

Related Comparisons